Edward Jones upgraded CVS Health from Hold to Buy
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/12/2026 | $94.00 | Mkt Perform → Outperform | Bernstein |
| 10/14/2025 | $91.00 | Buy | Goldman |
| 8/18/2025 | $79.00 | Neutral → Buy | UBS |
| 8/14/2025 | $82.00 | Neutral → Outperform | Robert W. Baird |
| 2/13/2025 | $55.00 → $75.00 | Market Perform → Outperform | Leerink Partners |
| 2/12/2025 | Neutral → Overweight | Cantor Fitzgerald | |
| 1/30/2025 | Hold → Buy | Edward Jones | |
| 12/3/2024 | $66.00 | Hold → Buy | Deutsche Bank |
Dog and cat owners can now fill common pet prescriptions at all CVS Pharmacy locations nationwideWOONSOCKET, R.I., July 21, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that common prescription medications for dogs and cats are now available at its approximately 9,000 CVS Pharmacy® locations nationwide. Pet owners can fill prescriptions for select pet-only medications, including antibiotics, allergy, flea and tick control, insulin, and pain relievers, at their local CVS Pharmacy, expanding access to essential pet health care. Greater flexibility in where pet prescriptions are filled helps reduce stress and delays, ensuring pets receive the medications they need conveniently w
Pharmacy-focused sites to open in select communities to help increase access to pharmacy careOpenings are part of ongoing commitment to serve communities and meet consumers where they are WOONSOCKET, R.I., July 17, 2026 /PRNewswire/ -- CVS Health® (NYSE:CVS) today unveiled its first pharmacy-focused CVS Pharmacy® in Houston. The new pharmacy, located at 8503A Gulf Freeway in south Houston, will help bridge gaps in pharmacy care and make it easier for community members to access medications, immunizations and other health care services provided by pharmacists. Nearly 20 pharmacy-focused locations will open in select communities
Providers give a 6.1 payer trust score, up from 5.4 in the previous study Providers weigh in on the potential of technology-enabled solutions to reduce administrative burden and save valuable timeHARTFORD, CT, July 15, 2026 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE:CVS) today announced findings from the second Aetna Provider Survey. The Aetna Provider Survey is a quarterly study that polls the U.S. provider market to better understand their perceptions on payers and the industry, today and into the future. This survey series is intended to solicit timely, objective feedback from the U.S. provider market so we can identify opportunities to change the provider-payer dynamic and deepe
11-K - CVS HEALTH Corp (0000064803) (Filer)
S-8 - CVS HEALTH Corp (0000064803) (Filer)
S-3ASR - CVS HEALTH Corp (0000064803) (Filer)
4 - CVS HEALTH Corp (0000064803) (Issuer)
4 - CVS HEALTH Corp (0000064803) (Issuer)
4 - CVS HEALTH Corp (0000064803) (Issuer)
Bernstein upgraded CVS Health from Mkt Perform to Outperform and set a new price target of $94.00
Goldman initiated coverage of CVS Health with a rating of Buy and set a new price target of $91.00
UBS upgraded CVS Health from Neutral to Buy and set a new price target of $79.00
4 - CVS HEALTH Corp (0000064803) (Issuer)
4 - CVS HEALTH Corp (0000064803) (Issuer)
4 - CVS HEALTH Corp (0000064803) (Issuer)
WOONSOCKET, R.I., Oct. 16, 2025 /PRNewswire/ -- CVS Health (NYSE:CVS) today announced it will support simpler access to more affordable fertility treatments for all Americans through its CVS Specialty Pharmacy and make it easier to pick up fertility medication at its 9,000 community pharmacy locations. CVS Specialty Pharmacy will be a core partner in the TrumpRx Fertility program. As the Trump Administration continues to establish more competitive prices for important medicines, the Administration has engaged with EMD Serono, manufacturer of Gonal-F an in-vitro fertilization (
Providing access to affordable care $0 copays on Tier 1 drugs & covered vaccines at in-network pharmacies1, $0 copay for colonoscopies and mammograms at in-network providers$0 copay for annual Healthy Home Visit from a licensed Signify Health clinicianContinued investment in technology, tools and teams that support our members Commitment to supporting unique member needs — those living with chronic conditions and individuals dually eligible for both Medicare and MedicaidLeveraging the strength of the CVS Health family of companies to deliver differentiated member experiencesWOONSOCKET, R.I., Oct. 1, 2025 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), today announced our 2026 Medi
WOONSOCKET, R.I., April 8, 2025 /PRNewswire/ -- CVS Health® (NYSE:CVS) today announced two leadership updates. Brian Newman has been named executive vice president and chief financial officer designate, effective April 21. He will succeed current chief financial officer, Tom Cowhey, who will transition to serve as a strategic advisor to president and chief executive officer David Joyner, effective May 12.Amy Compton-Phillips, M.D., is the company's new executive vice president and chief medical officer, effective May 19, also reporting to David Joyner.Based on year-to-date res
SC 13G - CVS HEALTH Corp (0000064803) (Subject)
SC 13G/A - CVS HEALTH Corp (0000064803) (Subject)
SC 13G/A - CVS HEALTH Corp (0000064803) (Subject)
WOONSOCKET, R.I., July 10, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The dividend is payable on August 3, 2026, to holders of record on July 23, 2026. About CVS HealthCVS Health is a leading health solutions company simplifying health care one person, one family and one community at a time. As of March 31, 2026, the Company had approximately 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics and a leading pharmacy be
WOONSOCKET, R.I., July 6, 2026 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, August 5, 2026, at 8:00 a.m. ET to discuss second quarter 2026 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year.About CVS HealthCVS Health is a leading health solutions company simplifying health care one person, one family and one community at a time. As of March 31, 2026, the Company had approximately 9,000 retail pharma
AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) of Aetna Life Insurance Company (ALIC) (Hartford, CT) and the other members of Aetna Health & Life Group, which are operating entities of Aetna Inc. (Aetna) and wholly owned subsidiaries of its ultimate parent, CVS Health Corporation (CVS Health) (NYSE:CVS). (Please see below for a detailed listing of the companies.)Concurrently, AM Best has affirmed the FSR of A (Excellent) and the Long-Term ICR of "a" (Excellent) of Allina Health and Aetna Insurance Company (Allina Health) (St. Louis Park, MN). Allina Health is a joint venture subsidiary of Ae